XML 41 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2017
Operating activities:      
Net income (loss) $ (724) $ (11,807) $ 14,092
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Stock-based compensation expense 9,637 8,950 5,478
Amortization of closing shares and earnout shares 0 355 1,579
Amortization of acquisition-related intangible assets 7,024 4,023 591
Depreciation and other amortization 1,388 615 322
Accretion and amortization on debt securities and other (134) (14) 30
Net change in the estimated fair value of acquisition-related contingent consideration 472 1,750 0
Deferred income taxes (3,775) 3,636 (11,065)
Changes in assets and liabilities:      
Accounts receivable 1,564 (5,673) (2,101)
Contract assets (1,757)    
Other assets (769) (1,676) 249
Accounts payable 28 309 593
Accrued payroll and related taxes (1,529) 2,553 429
Deferred revenue 1,125 1,670 (269)
Restructuring accrual 1,573 0 0
Other liabilities 127 935 517
Net cash provided by operating activities 14,250 5,626 10,445
Investing activities:      
Purchases of investments (24,410) (15,391) (39,939)
Sales and maturities of investments 14,966 41,018 32,650
Payments for business acquisitions, net of cash acquired 0 (29,744) 0
Purchases of property and equipment (1,063) (4,307) (488)
Net cash used in investing activities (10,507) (8,424) (7,777)
Financing activities:      
Proceeds from the issuance of equity plan common stock 5,581 1,125 687
Payment for acquisition-related contingent consideration (1,030) (1,284) 0
Proceeds from other borrowings 128 0 0
Principal payments on other borrowings (296) (270) 0
Net cash provided by (used in) financing activities 4,383 (429) 687
Foreign currency effect on cash and cash equivalents (406) (34) (76)
Net increase (decrease) in cash and cash equivalents 7,720 (3,261) 3,279
Cash and cash equivalents at beginning of period 9,028 12,289 9,010
Cash and cash equivalents at end of period 16,748 9,028 12,289
Supplemental disclosures of cash flow information:      
Cash paid for interest 0 29 0
Cash paid for income taxes 310 402 113
Supplemental disclosures of non-cash investing and financing activities:      
Unrealized holding gain (loss) on available for sale investments $ 29 $ (10) $ (19)